Harris Associates
LLY icon

Harris Associates’s Eli Lilly LLY Stock Holding History

Harris Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$414K Buy
450
+36
+9% +$36.5K ﹤0.01% 137
2025
Q4 		$445K Hold
414
– – ﹤0.01% 139
2025
Q3 		$316K Hold
414
– – ﹤0.01% 139
2025
Q2 		$323K Buy
+414
New +$322K ﹤0.01% 141
2015
Q2 		– Sell
-3,100
Closed -$225K – 151
2015
Q1 		$225K Sell
3,100
-710
-19% -$50.5K ﹤0.01% 164
2014
Q4 		$263K Buy
3,810
+110
+3% +$7.42K ﹤0.01% 173
2014
Q3 		$240K Hold
3,700
– – ﹤0.01% 169
2014
Q2 		$230K Hold
3,700
– – ﹤0.01% 175
2014
Q1 		$218K Buy
+3,700
New +$206K ﹤0.01% 176

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Harris Associates's LLY Position: Q1 2026 in Review

Harris Associates increased its Eli Lilly (LLY) stake by 8.7% in Q1 2026, buying an estimated $36.5K and bringing the position to 450 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #137.

Harris Associates first reported a position in LLY in Q1 2014 and has held it in 9 quarters since. The position peaked at $445K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Harris Associates held 450 shares of Eli Lilly worth $414K as of Q1 2026.
  • Harris Associates bought 36 Eli Lilly shares in Q1 2026, an estimated $36.5K.
  • Eli Lilly made up ﹤0.01% of Harris Associates's portfolio in Q1 2026, its #137 holding.
  • Harris Associates first reported a position in Eli Lilly in Q1 2014 and has held it in 9 quarters since.
  • Harris Associates's Eli Lilly position peaked at $445K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Harris Associates's 13F filing for Q1 2026, filed 15 May 2026.